✦ LIBER ✦

Pharmacodynamics of new HMG-CoA reductase inhibitor ZD4522 in patients with primary hypercholesterolaemia

✍ Scribed by A.G Olsson; J.S Pears; J McKellar; R.J Caplan; A Raza

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacological properties of ZD4522 — A

✍ G Smith; R Davidson; S Bloor; K Burns; C Calnan; P McAulay; N Torr; W Ward; F Mc 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Single- and multiple-dose pharmacokineti

✍ M.J Warwick; A.L Dane; A Raza; D.W Schneck 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 137 KB

New HMG-CoA reductase inhibitor ZD4522 l

✍ L. Havekes; H. van der Boom; J. Emeis; H. Princen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Effects of HMG CoA reductase inhibitors

✍ P. O'Connor; I. Graham; K. Robinson; J. Feely 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Effects of simvastatin, an HMG-CoA reduc

✍ Jonathan Isaacsohn; Donald Hunninghake; Helmut Schrott; Carlos A. Dujovne; Rober 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

A long-term comparative trial of cerivas

✍ Jun Sasaki; Kikuo Arakawa; Kyosuke Yamamoto; Shozo Kobori; Masato Ageta; Suminor 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 658 KB